Ventyx Biosciences Net Income

The latest net income for VTYX is $-110M as of September 2025. That compares with $-150M in the prior-year period — up 30.1% year over year. That is below the sector sector average of $98M. Investors often review this figure alongside Ventyx Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, VTYX's net income moved from $-150M to $-110M — a 30.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ventyx Biosciences's operating scale or balance-sheet position.

Against its sector companies, VTYX currently prints $-110M for net income, while the sector average sits near $98M. That is roughly 209.1% below the sector mean. Large gaps often invite a closer look at Ventyx Biosciences's growth, margins, and balance sheet.

A net income figure of $-110M for VTYX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $98M. Explore the charts below for those layers of context.

After noting VTYX's net income ($-110M), review year-over-year change from $-150M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.